{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:39:36Z","timestamp":1762522776219,"version":"3.41.2"},"reference-count":71,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T00:00:00Z","timestamp":1672790400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>Management of hemodynamically stable, incessant wide QRS complex tachycardia (WCT) in patients who already have an implantable cardioverter defibrillator (ICD) is challenging. First-line treatment is performed by medical staff who have no knowledge on programmed ICD therapy settings and there is always some concern for unexpected ICD shock. In these patients, a structured approach is necessary from presentation to therapy. The present review provides a systematic approach in four distinct phases to guide any physician involved in the management of these patients: PHASE I: assessment of hemodynamic status and use of the magnet to temporarily suspend ICD therapies, especially shocks; identification of possible arrhythmia triggers; risk stratification in case of electrical storm (ES). PHASE II: The preparation phase includes reversal of potential arrhythmia \u201ctriggers\u201d, mild patient sedation, and patient monitoring for therapy delivery. Based on resource availability and competences, the most adequate therapeutic approach is chosen. This choice depends on whether a device specialist is readily available or not. In the case of ES in a \u201chigh-risk\u201d patient an accelerated patient management protocol is advocated, which considers urgent ventricular tachycardia transcatheter ablation with or without mechanical cardiocirculatory support. PHASE III: Therapeutic phase is based on the use of intravenous anti-arrhythmic drugs mostly indicated in this clinical context are presented. Device interrogation is very important in this phase when sustained monomorphic VT diagnosis is confirmed, then ICD ATP algorithms, based on underlying VT cycle length, are proposed. In high-risk patients with intractable ES, intensive patient management considers MCS and transcatheter ablation. PHASE IV: The patient is hospitalized for further diagnostics and management aimed at preventing arrhythmia recurrences.<\/jats:p>","DOI":"10.3389\/fcvm.2022.1011619","type":"journal-article","created":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T16:07:03Z","timestamp":1672848423000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Management of hemodynamically stable wide QRS complex tachycardia in patients with implantable cardioverter defibrillators"],"prefix":"10.3389","volume":"9","author":[{"given":"Fran\u00e7ois D.","family":"Regoli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mattia","family":"Cattaneo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florenc","family":"Kola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albana","family":"Thartori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hekuran","family":"Bytyci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Saccarello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Amoruso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcello","family":"Di Valentino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Menafoglio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,1,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.118.006273","article-title":"Frequency of cardiac rhythm abnormalities in a half million adults.","volume":"11","author":"Khurshid","year":"2018","journal-title":"Circ Arrhythm Electrophysiol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1093\/europace\/euv188","article-title":"Incidence of and predictors for appropriate implantable cardioverter-defibrillator therapy in patients with a secondary preventive implantable cardioverter-defibrillator indication.","volume":"18","author":"Schaer","year":"2016","journal-title":"Europace."},{"key":"B3","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s10840-014-9941-8","article-title":"Ventricular tachyarrhythmia recurrence in primary versus secondary implantable cardioverter-defibrillator patients and role of electrophysiology study.","volume":"41","author":"Zaman","year":"2014","journal-title":"J Interv Card Electrophysiol."},{"key":"B4","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/eurheartj\/ehz467","article-title":"2019 ESC guidelines for the management of patients with supraventricular tachycardia. The task force for the management of patients with supraventricular tachycardia of the European society of cardiology (ESC).","volume":"41","author":"Brugada","year":"2021","journal-title":"Eur Heart J."},{"key":"B5","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.cjca.2020.04.004","article-title":"Members of the secondary panel. 2020 Canadian cardiovascular society\/Canadian heart rhythm society position statement on the management of ventricular tachycardia and fibrillation in patients with structural heart disease.","volume":"36","author":"Deyell","year":"2020","journal-title":"Can J Cardiol."},{"journal-title":"Gruppo di Lavoro Regionale, Regione Friuli Venezia Giulia. Percorso Assistenziale del Paziente con Tempesta Aritmica.","year":"2019","author":"Rebellato","key":"B6"},{"key":"B7","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.resuscitation.2021.02.010","article-title":"European resuscitation council guidelines 2021: adult advanced life support.","volume":"161","author":"Soar","year":"2021","journal-title":"Resuscitation."},{"key":"B8","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.ijcard.2020.08.089","article-title":"Comparison of transvenous vs subcutaneous defibrillator therapy in patients with cardiac arrhythmia syndromes and genetic cardiomyopathies.","volume":"323","author":"Kuschyk","year":"2021","journal-title":"Int J Cardiol."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3390\/jpm12040536","article-title":"Pooled analysis of complications with transvenous ICD compared to subcutaneous ICD in patients with catecholaminergic polymorphic ventricular arrhythmia.","volume":"12","author":"Eckert","year":"2022","journal-title":"J Pers Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1002\/clc.23247","article-title":"Implantable cardioverter-defibrillator in brugada syndrome: long-term follow-up.","volume":"42","author":"El-Battrawy","year":"2019","journal-title":"Clin Cardiol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1007\/s00392-019-01449-3","article-title":"Long-term follow-up of implantable cardioverter-defibrillators in Short QT syndrome.","volume":"108","author":"El-Battrawy","year":"2019","journal-title":"Clin Res Cardiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1093\/europace\/euq316","article-title":"Management of patients receiving implantable cardiac defibrillator shocks: recommendations for acute and long-term patient management.","volume":"12","author":"Braunschweig","year":"2010","journal-title":"Europace."},{"key":"B13","doi-asserted-by":"publisher","first-page":"13","DOI":"10.4414\/cvm.2016.00378","article-title":"Pre-, intra-and postoperative issues and management of pacemaker and defibrillator carriers in the setting of electrocautery Recommendations for the peri operative management of patients with cardiac implantable electronic devices.","volume":"19","author":"Sticherling","year":"2016","journal-title":"Cardiovasc Med."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11030691","article-title":"Perioperative management of patients with cardiac implantable electronic devices and utility of magnet application.","volume":"11","author":"\u00d6zkartal","year":"2022","journal-title":"J Clin Med."},{"key":"B15","first-page":"580","article-title":"Tachicardia a QRS larghi: un problema antico e nuovo [Wide QRS complex tachycardia: an old and new problem].","volume":"10","author":"Oreto","year":"2009","journal-title":"G Ital Cardiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1093\/europace\/euq430","article-title":"Diagnostic criteria of broad QRS complex tachycardia: decades of evolution.","volume":"13","author":"Alzand","year":"2011","journal-title":"Europace."},{"key":"B17","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1136\/hrt.66.2.166","article-title":"Multivariate analysis to simplify the differential diagnosis of broad complex tachycardia.","volume":"66","author":"Griffith","year":"1991","journal-title":"Br Heart J."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1016\/j.amjcard.2008.01.024","article-title":"Approach to the diagnosis and initial management of the stable adult patient with a wide complex tachycardia.","volume":"101","author":"Goldberger","year":"2008","journal-title":"Am J Cardiol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1161\/01.CIR.83.5.1621","article-title":"On the mechanisms of ventricular tachycardia acceleration during programmed electrical stimulation.","volume":"83","author":"Brugada","year":"1991","journal-title":"Circulation."},{"key":"B20","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.hrthm.2007.09.020","article-title":"New algorithm using only lead aVR for differential diagnosis of wide QRS complex tachycardia.","volume":"5","author":"Vereckei","year":"2008","journal-title":"Heart Rhythm."},{"key":"B21","doi-asserted-by":"publisher","first-page":"985","DOI":"10.7326\/M20-7844","article-title":"Appropriate use of point-of-care ultrasonography in patients with acute dyspnea in emergency department or inpatient settings: a clinical guideline from the american college of physicians.","volume":"174","author":"Qaseem","year":"2021","journal-title":"Ann Intern Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1007\/s00380-021-01844-9","article-title":"Electrical storm reveals worse prognosis compared to myocardial infarction complicated by ventricular tachyarrhythmias in ICD recipients.","volume":"36","author":"M\u00fcller","year":"2021","journal-title":"Heart Vessels."},{"key":"B23","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1093\/europace\/eut304","article-title":"Role of electrical storm as a mortality and morbidity risk factor and its clinical predictors: a meta-analysis.","volume":"16","author":"Guerra","year":"2014","journal-title":"Europace."},{"key":"B24","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.ahj.2008.06.035","article-title":"InSync ICD Italian registry investigators. Electrical storm in patients with biventricular implantable cardioverter defibrillator: incidence, predictors, and prognostic implications.","volume":"156","author":"Gasparini","year":"2008","journal-title":"Am Heart J."},{"key":"B25","doi-asserted-by":"publisher","first-page":"521","DOI":"10.4330\/wjc.v9.i6.521","article-title":"Management of ventricular tachycardia storm in patients with structural heart disease.","volume":"9","author":"Muser","year":"2017","journal-title":"World J Cardiol."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.937655","article-title":"Interaction between electrical storm and left ventricular ejection fraction as predictors of mortality in patients with implantable cardioverter defibrillator: a Chinese cohort study.","volume":"9","author":"Zhai","year":"2022","journal-title":"Front Cardiovasc Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1016\/j.jacc.2018.02.056","article-title":"Propranolol versus metoprolol for treatment of electrical storm in patients with implantable cardioverter-defibrillator.","volume":"71","author":"Chatzidou","year":"2018","journal-title":"J Am Coll Cardiol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"3381","DOI":"10.1161\/01.CIR.92.12.3381","article-title":"Long QT syndrome patients with mutations of the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate. Implications for gene-specific therapy.","volume":"92","author":"Schwartz","year":"1995","journal-title":"Circulation."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1111\/j.1540-8167.2008.01246.x","article-title":"Ranolazine shortens repolarization in patients with sustained inward sodium current due to type-3 long-QT syndrome.","volume":"19","author":"Moss","year":"2008","journal-title":"J Cardiovasc Electrophysiol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1016\/j.jacc.2004.02.034","article-title":"Short QT syndrome: pharmacological treatment.","volume":"43","author":"Gaita","year":"2004","journal-title":"J Am Coll Cardiol."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.007394","article-title":"Modeling short QT syndrome using human-induced pluripotent stem cell-derived cardiomyocytes.","volume":"7","author":"El-Battrawy","year":"2018","journal-title":"J Am Heart Assoc."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.00771","article-title":"Impact of antiarrhythmic drugs on the outcome of short QT syndrome.","volume":"10","author":"El-Battrawy","year":"2019","journal-title":"Front Pharmacol."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.010073","article-title":"Long-term follow-up of patients with short QT syndrome: clinical profile and outcome.","volume":"7","author":"El-Battrawy","year":"2018","journal-title":"J Am Heart Assoc."},{"key":"B34","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1093\/eurheartj\/ehv316","article-title":"2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the task force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European society of cardiology (ESC). Endorsed by: association for European paediatric and congenital cardiology (AEPC).","volume":"36","author":"Priori","year":"2015","journal-title":"Eur Heart J."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1111\/anec.12723","article-title":"Arrhythmic events in Brugada syndrome patients induced by fever.","volume":"25","author":"Roterberg","year":"2020","journal-title":"Ann Noninvasive Electrocardiol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"5019","DOI":"10.19102\/icrm.2022.130601","article-title":"Electrical storm in a patient with brugada syndrome and coronavirus disease 2019.","volume":"13","author":"Ali","year":"2022","journal-title":"J Innov Card Rhythm Manag."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1111\/jce.15596","article-title":"Fever following Covid-19 vaccination in subjects with Brugada syndrome: incidence and management.","volume":"33","author":"Santoro","year":"2022","journal-title":"J Cardiovasc Electrophysiol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1161\/CIRCULATIONAHA.108.829267","article-title":"Incidence and risk factors of arrhythmic events in catecholaminergic polymorphic ventricular tachycardia.","volume":"119","author":"Hayashi","year":"2009","journal-title":"Circulation."},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9040903","article-title":"Long-term follow-up of patients with catecholaminergic polymorphic ventricular arrhythmia.","volume":"9","author":"Veith","year":"2020","journal-title":"J Clin Med."},{"key":"B40","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/nm.1942","article-title":"Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans.","volume":"15","author":"Watanabe","year":"2009","journal-title":"Nat Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"S155","DOI":"10.1097\/01.CCM.0000115622.73988.6E","article-title":"Assessment and management of patients with pacemakers and implantable cardioverter defibrillators.","volume":"32","author":"Stone","year":"2004","journal-title":"Crit Care Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1161\/01.CIR.56.5.737","article-title":"Entrainment and interruption of atrial flutter with atrial pacing: studies in man following open heart surgery.","volume":"56","author":"Waldo","year":"1977","journal-title":"Circulation."},{"key":"B43","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1161\/01.CIR.0000145610.64014.E4","article-title":"Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: pacing fast ventricular tachycardia reduces shock therapies (PainFREE Rx II) trial results.","volume":"110","author":"Wathen","year":"2004","journal-title":"Circulation."},{"key":"B44","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1063\/1.166029","article-title":"External forcing of spiral waves.","volume":"4","author":"Zykov","year":"1994","journal-title":"Chaos."},{"key":"B45","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1161\/01.CIR.97.1.66","article-title":"Empirical versus tested antitachycardia pacing in implantable cardioverter defibrillators: a prospective study including 200 patients.","volume":"97","author":"Schaumann","year":"1998","journal-title":"Circulation."},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-019-1121-4","article-title":"Arrhythmic episodes in patients implanted with a cardioverter-defibrillator - results from the Prospective Study on Predictive Quality with Preferencing PainFree ATP therapies (4P).","volume":"19","author":"Regoli","year":"2019","journal-title":"BMC Cardiovasc Disord."},{"key":"B47","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1093\/europace\/euv411","article-title":"2015 HRS\/EHRA\/APHRS\/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.","volume":"18","author":"Wilkoff","year":"2016","journal-title":"Europace."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1093\/europace\/euz065","article-title":"2019 HRS\/EHRA\/APHRS\/LAHRS focused update to 2015 expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.","volume":"21","author":"Stiles","year":"2019","journal-title":"Europace."},{"key":"B49","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.jacc.2006.03.037","article-title":"A comparison of empiric to physician-tailored programming of implantable cardioverter-defibrillators: results from the prospective randomized multicenter EMPIRIC trial.","volume":"48","author":"Wilkoff","year":"2006","journal-title":"J Am Coll Cardiol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.jacc.2008.05.011","article-title":"Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study.","volume":"52","author":"Wilkoff","year":"2008","journal-title":"J Am Coll Cardiol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.1093\/eurheartj\/ehp247","article-title":"A simplified biventricular defibrillator with fixed long detection intervals reduces implantable cardioverter defibrillator (ICD) interventions and heart failure hospitalizations in patients with non-ischaemic cardiomyopathy implanted for primary prevention: the RELEVANT [Role of long dEtection window programming in patients with LEft VentriculAr dysfunction, Non-ischemic eTiology in primary prevention treated with a biventricular ICD] study.","volume":"30","author":"Gasparini","year":"2009","journal-title":"Eur Heart J."},{"key":"B52","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1161\/CIRCULATIONAHA.114.009468","article-title":"Efficacy of long detection interval implantable cardioverter-defibrillator settings in secondary prevention population: data from the avoid delivering therapies for nonsustained arrhythmias in ICD patients III (ADVANCE III) trial.","volume":"130","author":"Kloppe","year":"2014","journal-title":"Circulation."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1093\/europace\/euw032","article-title":"Different impact of long-detection interval and anti-tachycardia pacing in reducing unnecessary shocks: data from the ADVANCE III trial.","volume":"18","author":"Arenal","year":"2016","journal-title":"Europace."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.ahj.2010.02.007","article-title":"BIVentricular versus right ventricular antitachycardia pacing to terminate ventricular tachyarrhythmias in patients receiving cardiac resynchronization therapy: the ADVANCE CRT-D Trial.","volume":"159","author":"Gasparini","year":"2010","journal-title":"Am Heart J."},{"key":"B55","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.pcad.2008.01.003","article-title":"The role of the autonomic nervous system in sudden cardiac death.","volume":"50","author":"Vaseghi","year":"2008","journal-title":"Prog Cardiovasc Dis."},{"key":"B56","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1161\/CIRCRESAHA.116.304679","article-title":"Cardiac innervation and sudden cardiac death.","volume":"116","author":"Fukuda","year":"2015","journal-title":"Circ Res."},{"key":"B57","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/j.jacep.2017.06.006","article-title":"Efficacy of stellate ganglion blockade in managing electrical storm: a systematic review.","volume":"3","author":"Meng","year":"2017","journal-title":"JACC Clin Electrophysiol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1093\/europace\/euaa319","article-title":"Anatomical-based percutaneous left stellate ganglion block in patients with drug-refractory electrical storm and structural heart disease: a single-centre case series.","volume":"23","author":"Savastano","year":"2021","journal-title":"Europace."},{"key":"B59","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1161\/CIRCEP.114.002155","article-title":"Acute hemodynamic decompensation during catheter ablation of scar-related ventricular tachycardia: incidence, predictors, and impact on mortality.","volume":"8","author":"Santangeli","year":"2015","journal-title":"Circ Arrhythm Electrophysiol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1093\/europace\/euz202","article-title":"2019 HRS\/EHRA\/APHRS\/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias.","volume":"21","author":"Cronin","year":"2019","journal-title":"Europace."},{"key":"B61","doi-asserted-by":"publisher","first-page":"e281","DOI":"10.1097\/CCM.0000000000002089","article-title":"Effectiveness of extracorporeal life support for patients with cardiogenic shock due to intractable arrhythmic storm.","volume":"45","author":"Le Pennec-Prigent","year":"2017","journal-title":"Crit Care Med."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1093\/europace\/euaa371","article-title":"Mechanical circulatory support in the management of life-threatening arrhythmia.","volume":"23","author":"Della Bella","year":"2021","journal-title":"Europace."},{"key":"B63","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/ejhf.2333","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European society of cardiology (ESC). With the special contribution of the heart failure association (HFA) of the ESC.","volume":"24","author":"McDonagh","year":"2022","journal-title":"Eur J Heart Fail."},{"key":"B64","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1002\/ejhf.1922","article-title":"Epidemiology, pathophysiology and contemporary management of cardiogenic shock - a position statement from the heart failure association of the European society of cardiology.","volume":"22","author":"Chioncel","year":"2020","journal-title":"Eur J Heart Fail."},{"key":"B65","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1161\/CIRCULATIONAHA.106.686534","article-title":"Catheter ablation for the treatment of electrical storm in patients with implantable cardioverter-defibrillators: short- and long-term outcomes in a prospective single-center study.","volume":"117","author":"Carbucicchio","year":"2008","journal-title":"Circulation."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1016\/S0735-1097(00)00615-X","article-title":"Catheter ablation of ventricular tachycardia in patients with structural heart disease using cooled radiofrequency energy: results of a prospective multicenter study. Cooled RF Multi Center Investigators Group.","volume":"35","author":"Calkins","year":"2000","journal-title":"J Am Coll Cardiol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1161\/CIRCULATIONAHA.108.788604","article-title":"Irrigated radiofrequency catheter ablation guided by electroanatomic mapping for recurrent ventricular tachycardia after myocardial infarction: the multicenter thermocool ventricular tachycardia ablation trial.","volume":"118","author":"Stevenson","year":"2008","journal-title":"Circulation."},{"key":"B68","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.hrthm.2017.08.022","article-title":"Successful ventricular tachycardia ablation in patients with electrical storm reduces recurrences and improves survival.","volume":"15","author":"Vergara","year":"2018","journal-title":"Heart Rhythm."},{"key":"B69","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(09)61755-4","article-title":"Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial.","volume":"375","author":"Kuck","year":"2010","journal-title":"Lancet."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1161\/CIRCULATIONAHA.122.059598","article-title":"Does timing of ventricular tachycardia ablation affect prognosis in patients with an implantable cardioverter defibrillator? Results from the multicenter randomized PARTITA trial.","volume":"145","author":"Della Bella","year":"2022","journal-title":"Circulation."},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.116.004823","article-title":"Initial clinical experience with a new automated antitachycardia pacing algorithm: feasibility and safety in an ambulatory patient cohort.","volume":"10","author":"Yee","year":"2017","journal-title":"Circ Arrhythm Electrophysiol."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.1011619\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T16:07:09Z","timestamp":1672848429000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.1011619\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,4]]},"references-count":71,"alternative-id":["10.3389\/fcvm.2022.1011619"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2022.1011619","relation":{},"ISSN":["2297-055X"],"issn-type":[{"type":"electronic","value":"2297-055X"}],"subject":[],"published":{"date-parts":[[2023,1,4]]},"article-number":"1011619"}}